|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/085 | (2006.01) |
| C07C 255/54 | (2013.01) | ||
| C07C 255/54 | (2006.01) | ||
| C07C 255/56 | (2013.01) | ||
| C07D 213/85 | (2006.01) | ||
| C07C 205/22 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07C 313/06 | (2013.01) | ||
| C07C 317/22 | (2013.01) | ||
| C07C 317/24 | (2013.01) | ||
| C07C 317/32 | (2013.01) | ||
| C07C 317/34 | (2013.01) | ||
| C07C 317/36 | (2013.01) | ||
| C07C 317/40 | (2013.01) | ||
| C07C 317/42 | (2013.01) | ||
| C07C 317/44 | (2013.01) | ||
| C07C 317/46 | (2013.01) | ||
| C07C 317/48 | (2013.01) | ||
| C07C 323/22 | (2013.01) | ||
| C07C 381/10 | (2013.01) | ||
| C07D 213/89 | (2013.01) | ||
| C07D 231/56 | (2013.01) | ||
| C07D 213/65 | (2013.01) | ||
| C07C2602/04 | (2017.05) | ||
| C07C2602/08 | (2017.05) | ||
| C07C2602/10 | (2017.05) | ||
| C07C2603/94 | (2017.05) | ||
| A61K 31/10 | (2013.01) | ||
| A61K 31/09 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| C07C 311/29 | (2013.01) | ||
| C07D 213/85 | (2013.01) | ||
| A61P 13/12 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Patento numeris | 3586835 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19192594.0 |
| Europos patento paraiškos padavimo data | 2014-09-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-01-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361875674 P | 2013-09-09 | US | |
| 201461978421 P | 2014-04-11 | US |
| (72) |
DIXON, Darryl David , US
GRINA, Jonas , US
JOSEY, John A. , US
RIZZI, James P. , US
SCHLACHTER, Stephen T. , US
WALLACE, Eli M. , US
WANG, Bin , US
WEHN, Paul , US
XU, Rui , US
YANG, Hanbiao , US
|
| (73) |
Peloton Therapeutics, Inc. ,
2330 Inwood Road
Suite 226, Dallas, TX 75235-7323,
US
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING ARYL ETHERS |
| PHARMACEUTICAL COMPOSITIONS COMPRISING ARYL ETHERS |